The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action
Open accessAbstract
Cannabis has a long history of medical use. Although there are many cannabinoids present in cannabis, Δ9tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the two components found in the highest concentrations. CBD itself does not produce typical behavioral cannabimimetic effects and was thought not to be responsible for psychotropic effects of cannabis. Numerous anecdotal findings testify to the therapeutic effects of CBD, which in some cases were further supported by research findings. However, data regarding CBD’s mechanism of action and therapeutic potential are abundant and omnifarious. Therefore, we review the basic research regarding molecular mechanism of CBD’s action with particular focus on its analgesic potential. Moreover, this article describes the detailed analgesic and anti-inflammatory effects of CBD in various models, including neuropathic pain, inflammatory pain, osteoarthritis and others. The dose and route of the administration-dependent effect of CBD, on the reduction in pain, hyperalgesia or allodynia, as well as the production of pro and anti-inflammatory cytokines, were described depending on the disease model. The clinical applications of CBD-containing drugs are also mentioned. The data presented herein unravel what is known about CBD’s pharmacodynamics and analgesic effects to provide the reader with current state-of-art knowledge regarding CBD’s action and future perspectives for research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
Bisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059 · cited 1×
“Indeed, CBD administration increases AEA levels in rat brains in an N-acyl phosphatidylethanolamine phospholipase D dependent manner [45] and in human serum [46].”
BackgroundEffect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015
De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
Thiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30136-3 · Cited by 905
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 756
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H.-C., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 712
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Iffland, K., & Grotenhermen, F. (2017) · Cannabis & Cannabinoid Research · doi:10.1089/can.2016.0034 · Cited by 645
Johnson, J. R., Burnell-Nugent, M., Lossignol, D., Ganae-Motan, E. D., Potts, R., & Fallon, M. T. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.06.008 · Cited by 622
History of Cannabis and Its Preparations in Saga, Science, and Sobriquet
Russo, E. B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790144 · Cited by 621
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Showalter, V. M., Compton, D. R., Martin, B. R., & Abood, M. E. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20744-3 · Cited by 571
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 568
McPartland, J. M., Duncan, M., Di Marzo, V., & Pertwee, R. G. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12944 · Cited by 521
Rajesh, M., Mukhopadhyay, P., Bátkai, S., Patel, V., Saito, K., Matsumoto, S., Kashiwaya, Y., Horváth, B., Mukhopadhyay, B., Becker, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.033 · Cited by 499
Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497
Taylor, L., Gidal, B., Blakey, G., Tayo, B., & Morrison, G. (2018) · CNS Drugs · doi:10.1007/s40263-018-0578-5 · Cited by 471
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Devinsky, O., Patel, A. D., Thiele, E. A., Wong, M. H., Appleton, R., Harden, C. L., Greenwood, S., Morrison, G., Sommerville, K., On behalf of the GWPCARE1 Part A Study Group, et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005254 · Cited by 458
Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S. (2006) · Rheumatology · doi:10.1093/rheumatology/kei183 · Cited by 433
Nurmikko, T. J., Serpell, M. G., Hoggart, B., Toomey, P. J., Morlion, B. J., & Haines, D. (2007) · Pain · doi:10.1016/j.pain.2007.08.028 · Cited by 431
Portenoy, R. K., Ganae-Motan, E. D., Allende, S., Yanagihara, R., Shaiova, L., Weinstein, S., McQuade, R., Wright, S., & Fallon, M. T. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.01.003 · Cited by 420
Qin, N., Neeper, M. P., Liu, Y., Hutchinson, T. L., Lubin, M. L., & Flores, C. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0504-08.2008 · Cited by 396
Costa, B., Trovato, A. E., Comelli, F., Giagnoni, G., & Colleoni, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.006 · Cited by 395
De Gregorio, D., McLaughlin, R. J., Posa, L., Ochoa-Sanchez, R., Enns, J., Lopez-Canul, M., Aboud, M., Maione, S., Comai, S., & Gobbi, G. (2019) · Pain · doi:10.1097/j.pain.0000000000001386 · Cited by 393
Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs
Gamble, L.-J., Boesch, J. M., Frye, C. W., Schwark, W. S., Mann, S., Wolfe, L., Brown, H., Berthelsen, E. S., & Wakshlag, J. J. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00165 · Cited by 343
De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P. C., Orlando, P., & Di Marzo, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134809 · Cited by 336
Chemical Basis of Hashish Activity
Mechoulam, R., Shani, A., Edery, H., & Grunfeld, Y. (1970) · Science · doi:10.1126/science.169.3945.611 · Cited by 326
Controlled clinical trial of cannabidiol in Huntington's disease
Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk, R., Kennedy, K., & Schram, K. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90386-g · Cited by 320
Tham, M., Yilmaz, O., Alaverdashvili, M., Kelly, M. E. M., Denovan‐Wright, E. M., & Laprairie, R. B. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14440 · Cited by 316
Elmes, M. W., Kaczocha, M., Berger, W. T., Leung, K., Ralph, B. P., Wang, L., Sweeney, J. M., Miyauchi, J. T., Tsirka, S. E., Ojima, I., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618447 · Cited by 312
Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age
Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308 · cited 1×
“In spite of the limitations, numerous anecdotal findings testify to the therapeutic effects of CBD, including anticonvulsant, antipsychotic, anxiolytic, neuroprotective and sleep-promoting effects, which are further supported by research [6].”
Transdermal cannabidiol reduces inflammation and pain‐related behaviours in a rat model of arthritis
Hammell, D. C., Zhang, L. P., Ma, F., Abshire, S. M., McIlwrath, S. L., Stinchcomb, A. L., & Westlund, K. N. (2016) · European Journal of Pain · doi:10.1002/ejp.818 · Cited by 300
Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I
Adams, R., Hunt, M., & Clark, J. H. (1940) · Journal of the American Chemical Society · doi:10.1021/ja01858a058 · Cited by 298
Martin-Santos, R., A. Crippa, J., Batalla, A., Bhattacharyya, S., Atakan, Z., Borgwardt, S., Allen, P., Seal, M., Langohr, K., Farre, M., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884780 · Cited by 295
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Xiong, W., Cui, T., Cheng, K., Yang, F., Chen, S.-R., Willenbring, D., Guan, Y., Pan, H.-L., Ren, K., Xu, Y., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120242 · Cited by 288
Henstridge, C. M., Balenga, N. A. B., Ford, L. A., Ross, R. A., Waldhoer, M., & Irving, A. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-108670 · Cited by 285
van de Donk, T., Niesters, M., Kowal, M. A., Olofsen, E., Dahan, A., & van Velzen, M. (2019) · Pain · doi:10.1097/j.pain.0000000000001464 · Cited by 284
Ward, S. J., McAllister, S. D., Kawamura, R., Murase, R., Neelakantan, H., & Walker, E. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12439 · Cited by 276
Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
Kapur, A., Zhao, P., Sharir, H., Bai, Y., Caron, M. G., Barak, L. S., & Abood, M. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050187 · Cited by 274
Philpott, H. T., O'Brien, M., & McDougall, J. J. (2017) · Pain · doi:10.1097/j.pain.0000000000001052 · Cited by 268
Lynch, M. E., Cesar-Rittenberg, P., & Hohmann, A. G. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.02.018 · Cited by 266
Rock, E., Bolognini, D., Limebeer, C., Cascio, M., Anavi‐Goffer, S., Fletcher, P., Mechoulam, R., Pertwee, R., & Parker, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01621.x · Cited by 255
Pan, H., Mukhopadhyay, P., Rajesh, M., Patel, V., Mukhopadhyay, B., Gao, B., Haskó, G., & Pacher, P. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147181 · Cited by 251
Nabissi, M., Morelli, M. B., Santoni, M., & Santoni, G. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs328 · Cited by 248
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
Bakas, T., van Nieuwenhuijzen, P. S., Devenish, S. O., McGregor, I. S., Arnold, J. C., & Chebib, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.022 · Cited by 246
Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists
Thomas, B. F., Gilliam, A. F., Burch, D. F., Roche, M. J., & Seltzman, H. H. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37365-3 · Cited by 240
Johnson, J. R., Lossignol, D., Burnell-Nugent, M., & Fallon, M. T. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.07.014 · Cited by 236
Lichtman, A. H., Lux, E. A., McQuade, R., Rossetti, S., Sanchez, R., Sun, W., Wright, S., Kornyeyeva, E., & Fallon, M. T. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2017.09.001 · Cited by 234
Verrico, C. D., Wesson, S., Konduri, V., Hofferek, C. J., Vazquez-Perez, J., Blair, E., Dunner, K., Salimpour, P., Decker, W. K., & Halpert, M. M. (2020) · Pain · doi:10.1097/j.pain.0000000000001896 · Cited by 220
Xu, D. H., Cullen, B. D., Tang, M., & Fang, Y. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201020666191202111534 · Cited by 206
Inhibitory effects of cannabidiol on voltage-dependent sodium currents
Ghovanloo, M.-R., Shuart, N. G., Mezeyova, J., Dean, R. A., Ruben, P. C., & Goodchild, S. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004929 · Cited by 204
Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
Ross, H. R., Napier, I., & Connor, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707104200 · Cited by 199
Martínez-Pinilla, E., Varani, K., Reyes-Resina, I., Angelats, E., Vincenzi, F., Ferreiro-Vera, C., Oyarzabal, J., Canela, E. I., Lanciego, J. L., Nadal, X., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00744 · Cited by 199
Serpell, M., Ratcliffe, S., Hovorka, J., Schofield, M., Taylor, L., Lauder, H., & Ehler, E. (2014) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00445.x · Cited by 197
Kozela, E., Lev, N., Kaushansky, N., Eilam, R., Rimmerman, N., Levy, R., Ben‐Nun, A., Juknat, A., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01379.x · Cited by 190
Laux, L. C., Bebin, E. M., Checketts, D., Chez, M., Flamini, R., Marsh, E. D., Miller, I., Nichol, K., Park, Y., Segal, E., et al. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.03.015 · Cited by 187
King, K. M., Myers, A. M., Soroka‐Monzo, A. J., Tuma, R. F., Tallarida, R. J., Walker, E. A., & Ward, S. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13887 · Cited by 177
Capano, A., Weaver, R., & Burkman, E. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2019.1685298 · Cited by 176
Maione, S., Piscitelli, F., Gatta, L., Vita, D., De Petrocellis, L., Palazzo, E., de Novellis, V., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01063.x · Cited by 175
Szaflarski, J. P., Bebin, E. M., Cutter, G., DeWolfe, J., Dure, L. S., Gaston, T. E., Kankirawatana, P., Liu, Y., Singh, R., Standaert, D. G., et al. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.07.020 · Cited by 172
Schoedel, K. A., Szeto, I., Setnik, B., Sellers, E. M., Levy-Cooperman, N., Mills, C., Etges, T., & Sommerville, K. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.07.027 · Cited by 169
Laun, A. S., Shrader, S. H., Brown, K. J., & Song, Z.-H. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0031-9 · Cited by 166
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
Granja, A. G., Carrillo-Salinas, F., Pagani, A., Gómez-Cañas, M., Negri, R., Navarrete, C., Mecha, M., Mestre, L., Fiebich, B. L., Cantarero, I., et al. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9399-3 · Cited by 165
Rimmerman, N., Ben-Hail, D., Porat, Z., Juknat, A., Kozela, E., Daniels, M. P., Connelly, P. S., Leishman, E., Bradshaw, H. B., Shoshan-Barmatz, V, et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.471 · Cited by 162
Toth, C. C., Jedrzejewski, N. M., Ellis, C. L., & Frey, W. H. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-16 · Cited by 160
Ahrens, J., Demir, R., Leuwer, M., de la Roche, J., Krampfl, K., Foadi, N., Karst, M., & Haeseler, G. (2009) · Pharmacology · doi:10.1159/000201556 · Cited by 154
Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
Lowin, T., Tingting, R., Zurmahr, J., Claßen, T., Schneider, M., & Pongratz, G. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02892-1 · Cited by 147
Manini, A. F., Yiannoulos, G., Bergamaschi, M. M., Hernandez, S. H., Olmedo, R., Barnes, A. J., Winkel, G. H., Sinha, R., Jutras‐Aswad, D., Huestis, M. A., et al. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000118 · Cited by 139
Rodríguez-Muñoz, M., Onetti, Y., Cortés‐Montero, E., Garzón, J., & Sánchez‐Blázquez, P. (2018) · Molecular Brain · doi:10.1186/s13041-018-0395-2 · Cited by 134
Ward, S. J., Ramirez, M. D., Neelakantan, H., & Walker, E. A. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3182283486 · Cited by 133
Cannabinoid-induced changes in respiration of brain mitochondria
Fišar, Z., Singh, N., & Hroudová, J. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.09.002 · Cited by 133
Principles and Practice of Pharmacology for Anaesthetists
Calvey, T. N., & Williams, N. E. (2008) · Wiley eBooks · doi:10.1002/9781405194853 · Cited by 129
Cannabidiol-Δ 9 -tetrahydrocannabinol interactions on acute pain and locomotor activity
Britch, S. C., Wiley, J. L., Yu, Z., Clowers, B. H., & Craft, R. M. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.01.046 · Cited by 124
Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Gao, F., Coppola, G., Geschwind, D. H., & Vogel, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061462 · Cited by 121
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Toczek, M., & Malinowska, B. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.054 · Cited by 116
Jesus, C. H. A., Redivo, D. D. B., Gasparin, A. T., Sotomaior, B. B., de Carvalho, M. C., Genaro, K., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. S., Zanoveli, J. M., et al. (2019) · Brain Research · doi:10.1016/j.brainres.2019.03.014 · Cited by 116
Rock, E. M., Limebeer, C. L., & Parker, L. A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5034-1 · Cited by 114
GPR3 and GPR6, novel molecular targets for cannabidiol
Laun, A. S., & Song, Z.-H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.165 · Cited by 109
Wong, H., & Cairns, B. E. (2019) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2019.05.028 · Cited by 109
Yang, K. S., Galadari, S., Isaev, D. S., Petroianu, G. A., Shippenberg, T. S., & Öz, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162594 · Cited by 108
Thapa, D., Cairns, E. A., Szczesniak, A.-M., Toguri, J. T., Caldwell, M. D., & Kelly, M. E. M. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0041 · Cited by 107
Cannabis constituent synergy in a mouse neuropathic pain model
Casey, S. L., Atwal, N., & Vaughan, C. W. (2017) · Pain · doi:10.1097/j.pain.0000000000001051 · Cited by 106
Navarro, G., Reyes‐Resina, I., Rivas‐Santisteban, R., de Medina, V. S., Morales, P., Casano, S., Ferreiro‐Vera, C., Lillo, A., Aguinaga, D., Jagerovic, N., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.046 · Cited by 102
Hegde, V. L., Singh, U. P., Nagarkatti, P. S., & Nagarkatti, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401844 · Cited by 100
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.101980 · Cited by 100
Hoggart, B., Ratcliffe, S. H., Ehler, E., Simpson, K. H., Hovorka, J., Lejčko, J., Taylor, L., Lauder, H., & Serpell, M. G. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7502-9 · Cited by 92
Russo, M., Naro, A., Leo, A., Sessa, E., D’Aleo, G., Bramanti, P., & Calabrò, R. S. (2016) · Pain Medicine · doi:10.1093/pm/pnv080 · Cited by 92
Abraham, A. D., Leung, E. J. Y., Wong, B. A., Rivera, Z. M. G., Kruse, L. C., Clark, J. J., & Land, B. B. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0585-3 · Cited by 91
Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay
Cuñetti, L., Manzo, L., Peyraube, R., Arnaiz, J., Curi, L., & Orihuela, S. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2017.12.042 · Cited by 90
Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors
Mahgoub, M., Keun-Hang, S. Y., Sydorenko, V., Ashoor, A., Kabbani, N., Kury, L. A., Sadek, B. S., Howarth, C. F., Isaev, D. S., Galadari, S., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.011 · Cited by 85
Britch, S. C., Goodman, A. G., Wiley, J. L., Pondelick, A. M., & Craft, R. M. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.263319 · Cited by 82
Finn, D. P., Beckett, S. R. G., Roe, C. H., Madjd, A., Fone, K. C. F., Kendall, D. A., Marsden, C. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03177.x · Cited by 77
6ʺ-Azidohex-2ʺ-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist
Thomas, A., Ross, R. A., Saha, B., Mahadevan, A., Razdan, R. K., & Pertwee, R. G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.023 · Cited by 76
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes
Lehmann, C., Fisher, N. B., Tugwell, B. D., Szczesniak, A. M., Kelly, M. E. M., & Zhou, J. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-168021 · Cited by 70
Li, H., Kong, W., Chambers, C. R., Yu, D., Ganea, D., Tuma, R. F., & Ward, S. J. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.02.016 · Cited by 70
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice
Harris, H., Sufka, K., Gul, W., & ElSohly, M. (2016) · Planta Medica · doi:10.1055/s-0042-106303 · Cited by 69 · cited 1×
“In cisplatin-induced neuropathy, CBD reduced neuropathic pain in mice but did not prevent pain development, when administered 30 min prior to cisplatin [75].”
BackgroundCannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease
Nascimento, G. C., Ferrari, D. P., Guimarães, F. S., Bel, E. A. D., Bortolanza, M., & Ferreira‐Junior, N. C. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107808 · Cited by 69
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein
Huang, H., McIntosh, A. L., Martin, G. G., Landrock, D., Chung, S., Landrock, K. K., Dangott, L. J., Li, S., Kier, A. B., & Schroeder, F. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00446 · Cited by 67
Cannabidiol, a novel inverse agonist for GPR12
Brown, K. J., Laun, A. S., & Song, Z.-H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.001 · Cited by 64
Jenny, M., Santer, E., Pirich, E., Schennach, H., & Fuchs, D. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.004 · Cited by 62
Leishman, E., Manchanda, M., Thelen, R., Miller, S., Mackie, K., & Bradshaw, H. B. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0031 · Cited by 61
Genaro, K., Fabris, D., Arantes, A. L. F., Zuardi, A. W., Crippa, J. A. S., & Prado, W. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00391 · Cited by 58
Cannabidiol Improves Vasorelaxation in Zucker Diabetic Fatty Rats through Cyclooxygenase Activation
Wheal, A. J., Cipriano, M., Fowler, C. J., Randall, M. D., & O’Sullivan, S. E. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217125 · Cited by 56
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice
Neelakantan, H., Tallarida, R. J., Reichenbach, Z. W., Tuma, R. F., Ward, S. J., & Walker, E. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000119 · Cited by 55
Bian, Y., He, X., Jing, Y., Wang, L.-R., Wang, J., & Xie, X. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0071-1 · Cited by 55
Marijuana extracts possess the effects like the endocrine disrupting chemicals
Watanabe, K., Motoya, E., Matsuzawa, N., Funahashi, T., Kimura, T., Matsunaga, T., Arizono, K., & Yamamoto, I. (2004) · Toxicology · doi:10.1016/j.tox.2004.08.005 · Cited by 54
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
Karmaus, P. W. F., Wagner, J. G., Harkema, J. R., Kaminski, N. E., & Kaplan, B. L. F. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.741628 · Cited by 54
Mijangos-Moreno, S., Poot-Aké, A., Arankowsky‐Sandoval, G., & Murillo‐Rodríguez, E. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.04.006 · Cited by 49
Takeda, S., Usami, N., Yamamoto, I., & Watanabe, K. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026930 · Cited by 46
Ladha, K. S., Ajrawat, P., Yang, Y., & Clarke, H. A. (2020) · Molecules · doi:10.3390/molecules25184042 · Cited by 43
Moreno‐Martet, M., Feliú, A., Espejo‐Porras, F., Mecha, M., Carrillo-Salinas, F. J., Fernández‐Ruíz, J., Guaza, C., & de Lago, E. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.08.001 · Cited by 42
Cannabidiol-induced lymphopenia does not involve NKT and NK cells.
Ignatowska-Jankowska, B. M., Jankowski, M. M., Glac, W., & Swiergel, A. H. (2009) · PubMed · Cited by 41
Linher‐Melville, K., Zhu, Y. F., Sidhu, J., Parzei, N., Shahid, A., Seesankar, G., Ma, D., Wang, Z., Zacal, N., Sharma, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234176 · Cited by 40
Activation of phospholipase A2 by cannabinoids: Lack of correlation with CNS effects
EVANS, A. T., Formukong, E. A., & Evans, F. J. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81420-5 · Cited by 39
Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol
Greene, N. Z., Wiley, J. L., Yu, Z., Clowers, B. H., & Craft, R. M. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5036-z · Cited by 39
Koch, M., Dehghani, F., Habazettl, I., Schomerus, C., & Korf, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03873.x · Cited by 28
Winklmayr, M., Gaisberger, M., Kittl, M., Fuchs, J., Ritter, M., & Jakab, M. (2019) · Journal of Orthopaedic Research® · doi:10.1002/jor.24430 · Cited by 25
The Therapeutic Effectiveness of Full Spectrum Hemp Oil Using a Chronic Neuropathic Pain Model
Vigil, J. M., Montera, M. A., Pentkowski, N. S., Diviant, J. P., Orozco, J., Ortiz, A. L., Rael, L. J., & Westlund, K. N. (2020) · Life · doi:10.3390/life10050069 · Cited by 23
Santoro, M., Massimiliano Mirabella, A., Fino, C. D., Bianco, A. D., Lucchini, M., Losavio, F. A., Sabino, A., & Nociti, V. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.06.017 · Cited by 17
Cited by
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13710 · Cited by 282
Metadata
- Authors
- Mlost, J., Bryk, M., & Starowicz, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-23
- Volume
- 21
- Issue
- 22
- Pages
- 8870
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3107035738
- Cited by
- 285
- References
- 123
- FWCI
- 16.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.